Saint Thomas Hospital
Panama City, Provincia de Panamá, Panama
NCT Number: NCT07265336
The study's primary goal is to compare the base excess (BE) values-an indicator of metabolic changes-in two groups of patients at Santo Tomás Hospital: those with severe preeclampsia and healthy, pregnant individuals. Researchers will measure these values using an arterial blood gas test before delivery or surgery.
This is a prospective cohort study. The researchers will analyze various blood gas parameters, including pH, lactate, and BE, and then correlate the BE values with clinical variables and negative maternal outcomes.
The expected outcome is that a abnormal BE values will be linked to a greater severity of preeclampsia. If this association is confirmed, BE could serve as an additional marker for predicting the severity of the condition and may lay the groundwork for future research on diagnostic and therapeutic standards based on blood gas analysis.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Panama City, Provincia de Panamá, Panama
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Determination of Excess Base in arterial blood gases before delivery / termination of pregnancy
Time frame: Immediately before delivery
Total measure of excess base measured by gasometry in an arterial blood sample
Time frame: From admission to day three (3) after delivery
Elevation of the blood pressure above 160 (systolic) and 110 (diastolic).
Time frame: Immediately before delivery
Concentration of lactate measured by gasometry in a sample of arterial blood.
Time frame: Immediately before delivery
Concentration of bicarbonate measured by gasometry in arterial blood gases
Saint Thomas Hospital, Panama
Other
Comparison of Base Excess in Arterial Blood Gases Between Patients With Severe Preeclampsia and Normotensive Pregnant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07190846
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Tunis, Tunisia
View Trial DetailsNCT02379832
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Québec, Canada
View Trial DetailsNCT02189148
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Calgary, Alberta, Canada
View Trial DetailsNCT07703826
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
View Trial Details